En | De
No articles selected!     View Cart  
You are here: Oncology » Respiratory Tract 18. June 2024
Respiratory Tract
Advanced search
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Musculoskeletal System
Endocrine System
Gynecologic Neoplasms
Respiratory Tract
Urologic Neoplasms
Respiratory Tract
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 7099  Previews Next
   Articles 1 - 20 / 141970  
Long-term exposure to air pollution on cardio-respiratory, and lung cancer mortality: a systematic review and meta-analysis.
J Environ Health Sci Eng
Karimi B, Samadi S.
PMID: 38887768 [PubMed]

Predictive model based on multiple immunofluorescence quantitative analysis for pathological complete response to neoadjuvant immunochemotherapy in lung squamous cell carcinoma.
Front Oncol
Xiao M, Tu L, Zhou T, He Y, Li X, Zuo Q.
PMID: 38887237 [PubMed]

Immune-related adverse events and their effects on survival outcomes in patients with non-small cell lung cancer treated with immune checkpoint inhibitors: a systematic review and meta-analysis.
Front Oncol
Liang Y, Xu H, Liu F, Li L, Lin C, Zhang Y, Wang N, Wang L.
PMID: 38887231 [PubMed]

Symptom clusters and their impacts on the quality of life of patients with lung cancer receiving immunotherapy: A cross-sectional study.
J Clin Nurs
Yang X, Bai J, Zhang J, Wang Y, Zhao H, Zhu X.
PMID: 38886988 [PubMed - as supplied by publisher]

Exploring the immune landscape and drug prediction of an M2 tumor-associated macrophage-related gene signature in EGFR-negative lung adenocarcinoma.
Thorac Cancer
Huang Y, Zhang Y, Duan X, Hou R, Wang Q, Shi J.
PMID: 38886907 [PubMed - as supplied by publisher]

Immune checkpoint inhibitor-induced cardiotoxicity in patients with lung cancer: a systematic review and meta-analysis.
Yamani N, Ahmed A, Ruiz G, Zubair A, Arif F, Mookadam F.
PMID: 38886852 [PubMed]

CTR > 0.7 predicts the subgroup of lung adenocarcinomas ≤ 2 cm at risk of poor outcome treated by sublobar resection compared to lobar resection.
Cancer Imaging
Jing W, Li Q, Liu M, Zhang Y, Chen S, Zhang K, Li D, Zhao M, Zheng Y, Li W, Wu Y, Xu H, Zhao Z, Kang S, Lv F.
PMID: 38886780 [PubMed - indexed for MEDLINE]

Prognostic biomarker tumor-infiltrating lymphocytes failed to serve as a predictive biomarker for postoperative radiotherapy in completely resected pN2 non-small cell lung cancer: a retrospective analysis.
Respir Res
Li J, Li L, Wang J, Liu N, Liu H, Xu F, Li M, Yuan S.
PMID: 38886760 [PubMed - indexed for MEDLINE]

Development and validation of a risk prediction model for invasiveness of pure ground-glass nodules based on a systematic review and meta-analysis.
BMC Med Imaging
Yang Y, Zhang L, Wang H, Zhao J, Liu J, Chen Y, Lu J, Duan Y, Hu H, Peng H, Ye L.
PMID: 38886695 [PubMed - indexed for MEDLINE]

The Proposed 9th Edition TNM Classification of Lung Cancer.
Detterbeck FC, Woodard GA, Bader AS, Dacic S, Grant MJ, Park HS, Tanoue LT.
PMID: 38885896 [PubMed - as supplied by publisher]

Biological and therapeutic implications of the cancer-related germline mutation landscape in lung cancer.
Lancet Respir Med
Panagiotou E, Vathiotis IA, Makrythanasis P, Hirsch F, Sen T, Syrigos K.
PMID: 38885686 [PubMed - as supplied by publisher]

Association of CTACK, IL-2, and IL-13 with increased risk of lung cancer: A Mendelian randomization study.
Liu Z, Zheng Y, Yuan M, Zhang G, Yang G.
PMID: 38885591 [PubMed - as supplied by publisher]

Erratum: Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR- or ALK-Mutated Non-Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04).
J Clin Oncol

PMID: 38885462 [PubMed - as supplied by publisher]

Effect of exercise on postoperative recovery of patients with non-small cell lung cancer: a systematic review and meta-analysis.
Discov Oncol
Jiao M, Liang H, Zhang M.
PMID: 38884823 [PubMed]

Bronchoalveolar Lavage Fluid Microbiota is Associated with the Diagnosis and Prognosis Evaluation of Lung Cancer.
Cheng C, Wang Z, Ding C, Liu P, Xu X, Li Y, Yan Y, Yin X, Chen B, Gu B.
PMID: 38884058 [PubMed]

Lung tumor discrimination by deep neural network model CanDo via DNA methylation in bronchial lavage.
Yu Z, Li J, Deng Y, Li C, Ye M, Zhang Y, Huang Y, Wang X, Zhao X, Liu J, Liu Z, Yin X, Mei L, Hou Y, Hu Q, Huang Y, Wang R, Fu H, Qiu R, Xu J, Gong Z, Zhang D, Zhang X.
PMID: 38883836 [PubMed]

Presurgical invasive mediastinal staging in lung cancer, unexpected N2 and long-term survival: a registry-based study with data from the Spanish group for video-assisted thoracic surgery.
J Thorac Dis
Lpez I, Aguinagalde B, Urreta I, Royo I, Bolufer S, Snchez L, Zabaleta J, Fernndez-Monge A, Embn R.
PMID: 38883688 [PubMed]

Increasing serum complement component 1q is associated with worse prognosis in advanced non-small cell lung cancer treated with immune checkpoint inhibitors: a single-center, retrospective study.
J Thorac Dis
Tang J, Fu Y, Song Y, Yin J, Wang J, Arasanz H, Zhang B.
PMID: 38883687 [PubMed]

Treatment rationale and protocol design: an investigator-initiated phase II study of combination treatment of nivolumab and TM5614, a PAI-1 inhibitor for previously treated patients with non-small cell lung cancer.
J Thorac Dis
Masuda T, Hirata T, Sakamoto T, Tsubata Y, Ichihara E, Kozuki T, Shoda H, Motonaga M, Yoshida T, Fukutani M, Tsuji-Takayama K, Tamura A, Amagase H, Fujihara H, Aoki G, Akita T, Orihashi Y, Miyata T, Hattori N.
PMID: 38883673 [PubMed]

Multimodal prehabilitation in patients with non-small cell lung cancer: a feasibility study.
J Thorac Dis
Ten Cate DWG, van den Berg R, Scholten-Bakker M, Molenaar CJL, von Meyenfeldt EM, Slooter GD, van den Broek FJC, Marres GMH.
PMID: 38883662 [PubMed]

   Articles 1 - 20 / 141970    Page 1 of 7099  Previews Next

Rect Bottom
Adserver Footer





Forgot your username or password?


New User? Sign Up

Register to My Medline!


Learn more about the My Medline experience

more >>

  Time frame  

Sky right 1